Gan & Lee Pharmaceuticals. (SHA: 603087)
China
· Delayed Price · Currency is CNY 42.17
-1.93 (-4.38%)
Jan 2, 2025, 3:00 PM CST
Gan & Lee Pharmaceuticals. Market Cap
Gan & Lee Pharmaceuticals. has a market cap or net worth of 25.08 billion as of January 3, 2025. Its market cap has decreased by -28.67% in one year.
Market Cap
25.08B
Enterprise Value
20.02B
Revenue
2.95B
Ranking
n/a
PE Ratio
42.61
Stock Price
42.17
Market Cap Chart
Since June 29, 2020, Gan & Lee Pharmaceuticals.'s market cap has decreased from 36.57B to 25.08B, a decrease of -31.41%. That is a compound annual growth rate of -8.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 25.08B | -4.74% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | 74.25B | 103.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 294.68B |
| Jiangsu Hengrui Medicine | 282.07B |
| WuXi AppTec | 150.16B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.98B |
| Aier Eye Hospital Group | 116.12B |
| Shanghai United Imaging Healthcare | 103.88B |
| Yunnan Baiyao Group Co.,Ltd | 103.58B |
| Beijing Wantai Biological Pharmacy Enterprise | 89.42B |